Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

By Brown Patrick   Smith Franklin O.  

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 42-51

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies for the myeloid leukaemias

By Maslak P.   Scheinberg D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1197-1205

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic approaches to acute myeloid leukemia

By Uchida Hideo   Inokuchi Koiti   Watanabe Reiko   Tokuhira Michihide   Kizaki Masahiro  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 689-706

Informa Healthcare

Access to resources Recommend Favorite

Perifosine – a new option in treatment of acute myeloid leukemia?

By Krawczyk Janusz   Keane Niamh   Swords Ronan   O'Dwyer Michael   Freeman Ciara L   Giles Francis J  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1315-1327

Informa Healthcare

Access to resources Recommend Favorite